The size of the Asia Pacific Mammography Market is predicted to reach USD 456.33 million by 2025 from its current value of USD 320 million in 2020, growing at a significant CAGR of 7.3% between 2020 to 2025.
While breast cancer prevails as one of the deadliest diseases among women, the need for early diagnosis of breast cancer has increased rising the demand for mammography. With the increasing mortality rate of breast cancer patients, the demand for these devices is likely to sustain in the foreseeable future.
Mammography is a standard diagnostic and screening devices used in examining the breast tissues with the help of images for the presence of any malignant tissues. The detailed imaging of the inside of the breast is made possible with the low dose x-ray system for the early-stage detection of cancer. While screening mammography involves random checking among women without any signs of breast cancer, diagnostic mammography involves checking of cancer if there are any specific symptoms related to breast cancer. It is also used to evaluate the results of a screening mammogram.
Rising cancer population, the evolvement of new breast imaging technologies, the rising aging population, increasing awareness regarding cancer symptoms are driving the growth of the mammography market. However, the market is hindered by the considerable cost incurred, stringent regulatory laws and side effects that are associated with the mammography.
This research report on the Asia Pacific Mammography Market has been segmented and sub-segmented the Asia Pacific Mammography Market into the following categories:
By Product:
By Technology:
By Application:
By Country:
Regional Analysis:
In Japan, the prevalence of breast cancer is significantly increasing over the past few years. Around 14000 women are dying due to breast cancer every year in Japan, which is creating more demand for the mammography systems in this country and is favouring the market growth. Japan also adopted a soft-copy reading of digital mammography for very complex processes. Mammography Subcommittee of the Japan Radiological Society arranges the campaign to spread information about mammography and breast cancer.
In Australia, Breast cancer is the second largest cause of women deaths and is the most lucrative region for the mammography market to grow in the near future. The Australian mammography market is estimated to display a robust CAGR during the forecast period.
Disorganised population-based mammography programs for breast cancer in India, limited availability of mammography units, trained radiologists are majorly driving the 1qmammography market in India. Many of the senior breast radiologists of India are working in Pan Indian mammography Society, which is estimated to propel the Indian mammography market growth.
Some of the promising companies leading the Asia Pacific Mammography Market profiled in the report include Fujifilm, GE Healthcare, Hologic, Metaltronica, Philips Healthcare, Planmed, Siemens Healthcare, Sonocine, and Toshiba Medical Systems.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 3D mammograms
5.1.3 Digital System
5.1.4 Analog System
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Technology
5.2.1 Introduction
5.2.2 Analog Mammography
5.2.3 Digital Mammography
5.2.4 Breast Tomosynthesis
5.2.5 Y-o-Y Growth Analysis, By Type
5.2.6 Market Attractiveness Analysis, By Type
5.2.7 Market Share Analysis, By Type
5.3 Application
5.3.1 Introduction
5.3.2 Screening Mammograms
5.3.3 Diagnostic Mammograms
5.3.4 Other Applications
5.3.5 Y-o-Y Growth Analysis, By Application
5.3.6 Market Attractiveness Analysis, By Application
5.3.7 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Technology
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Tecchnology
6.1.4.4 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Technology
6.1.5.4 By Application
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 GE Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Siemens Healthcare
8.3 Toshiba Medical Systems
8.4 Metaltronica
8.5 Sonocine Inc.
8.6 Fujifilm
8.7 Hologic Inc.
8.8 Philips Healthcare
8.9 Planmed
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
